Today: 7 February 2026
Subscribe

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier biotech names again, and ADPT tends to swing with that tone. The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF were each up about 2.5% in midday trade. The broader market was also higher, but not by as
7 January 2026
·····
AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

New York, Jan 7, 2026, 12:42 (EST) — Regular session AST SpaceMobile, Inc. (ASTS) fell 8.5% to $89.18 in midday trading on Wednesday after Scotiabank cut the satellite communications company to sector underperform. The stock opened at $91 and hit a session low of $88.49 as volume rose past 12.3 million shares. The downgrade hits after a sharp run that has pushed the stock close to its highs and made valuation the central argument. Shares have more than tripled over the past 12 months, even though the company is not expected to post positive operating profit until 2027. Barron’s Scotiabank
7 January 2026
····
Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

MUMBAI, January 7, 2026, 23:15 (IST) Vedanta Ltd shares touched a 52-week high of 629.90 rupees on Wednesday before giving back most of the move, ending almost flat at 622 rupees. Business Today The jump mattered because it came in a choppy session for Indian stocks, with investors scanning trade and geopolitical headlines ahead of the earnings season. “Markets remain sensitive to trade and geopolitical developments,” said Hitesh Tailor, a research analyst at Choice Equity Broking. Reuters Brokerage targets have moved up as the rally has stretched into a month-long run. Kotak Securities has a target of 650 rupees, Investec
7 January 2026
·····
CMB.Tech NV stock closes up 4% in Brussels — dividend timing, “freeze period” and next dates in focus

CMB.Tech NV stock closes up 4% in Brussels — dividend timing, “freeze period” and next dates in focus

BRUSSELS, Jan 7, 2026, 18:20 CET — Market closed CMB.Tech NV shares closed up 4.1% at 8.89 euros in Brussels on Wednesday, taking their gain over the past five sessions to about 9.6%. The stock finished near a one-week high after the shipping group flagged the trading and payment timetable for an interim dividend. MarketScreener The dates matter now because the record date — when share ownership is checked for dividend eligibility — falls on Wednesday for the Brussels and New York lines, while the company has also imposed a short “freeze period” that temporarily blocks share repositioning between registers.
7 January 2026
···
Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

New York, January 7, 2026, 12:32 (EST) — Regular session Shares of Legend Biotech Corp rose 7.4% to $22.53 in midday trading on Wednesday after Oppenheimer initiated coverage with an “Outperform” rating and set a $75 price target, according to MarketBeat. StreetInsider said Oppenheimer analyst Trevor Allred authored the initiation note. MarketBeat Why it matters now: Legend’s stock has been under pressure and touched a 52-week low of $21.16 earlier this week, keeping investors sensitive to any shift in the narrative around its lead product, Carvykti. Carvykti is a CAR‑T therapy — a personalized cancer treatment that uses a patient’s
7 January 2026
·····
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

New York, Jan 7, 2026, 12:23 (EST) — Regular session Mastercard Incorporated (NYSE:MA) shares rose 0.7% to $584.60 on Wednesday, after trading between $577.52 and $584.60. About 1.36 million shares had changed hands by late morning. The move came in a mixed session for U.S. stocks. The S&P 500-tracking SPY was up about 0.3% while the Dow-linked DIA slipped 0.1%; tech-heavy QQQ gained about 0.7%. Labor data kept risk appetite in check ahead of Friday’s government jobs report. U.S. private payrolls rose 41,000 in December, below economists’ forecasts, ADP data showed. Morgan Stanley kept Mastercard rated “overweight” — a call
7 January 2026
····
Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom

Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom

NEW YORK, Jan 7, 2026, 12:25 EST — Regular session Nokia Oyj’s U.S.-listed shares climbed 5.9% to $6.86 in midday trade on Wednesday after Kepler Cheuvreux upgraded the Finnish telecom equipment maker to “buy,” according to StreetInsider. StreetInsider.com The call landed after a roughly 15% pullback from recent highs, which Kepler said had opened a better entry point. The broker raised its target price to 6.60 euros from 5 euros and called Nokia’s valuation “rather reasonable” at about 13 times its 2026 estimated EBIT — earnings before interest and taxes. Investing.com That matters now because Nokia is heading into its
7 January 2026
····
Uber stock gains as CES robotaxi testing update puts autonomy back in focus

Uber stock gains as CES robotaxi testing update puts autonomy back in focus

NEW YORK, Jan 7, 2026, 12:14 EST — Regular session Uber Technologies (UBER) shares climbed on Wednesday, up about 1.7% at $87.03 in midday New York trading, after the company and partners detailed progress on a planned robotaxi service tied to the Uber app. Source The move landed as U.S. stocks turned mixed and investors sized up fresh labor data ahead of Friday’s monthly jobs report, a potential swing factor for rate bets and high-growth names. Source For Uber, autonomy is back in the conversation because it sits at the intersection of two things shareholders keep circling: whether the company
7 January 2026
····
Firefly Aerospace stock jumps as traders look past fresh class-action reminders

Firefly Aerospace stock jumps as traders look past fresh class-action reminders

NEW YORK, Jan 7, 2026, 12:14 (EST) — Regular session Firefly Aerospace Inc shares rose on Wednesday, swinging sharply after the open even as new law-firm notices about a securities class-action lawsuit spread across newswires. The stock was up 8.5% at $28.69, after trading as low as $25.39 and as high as $29.00. The move matters because Firefly has been trading like a headline stock since its 2025 listing, and the latest legal reminders land days before a Jan. 12 deadline for investors to seek lead-plaintiff status in the case — the shareholder who would represent the class and direct
7 January 2026
·····
Apellis stock jumps nearly 8% as investors look to JPM healthcare update

Apellis stock jumps nearly 8% as investors look to JPM healthcare update

New York, Jan 7, 2026, 12:14 PM EST — Regular session Apellis Pharmaceuticals shares rose nearly 8% on Wednesday, outperforming the broader market as traders positioned ahead of the company’s scheduled appearance at next week’s J.P. Morgan Healthcare Conference. investors.apellis.com The Waltham, Massachusetts-based drugmaker said on Monday it will present on Jan. 12 at 11:15 a.m. PT, with a live webcast posted to its investor site and a replay available afterward. Big healthcare conferences often bring fresh guidance, new trial details or partnering chatter — and the tape tends to price that in early. investors.apellis.com Apellis was last up $1.91
7 January 2026
·····
DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

DHT Holdings stock jumps as tanker shares rally on Venezuela oil shake-up

NEW YORK, Jan 7, 2026, 11:52 (EST) — Regular session Shares of DHT Holdings, Inc. rose 6.6% to $12.81 on Wednesday, extending a broad rally in U.S.-listed tanker stocks during the regular session. Frontline gained about 8%, Teekay Tankers added about 9%, Scorpio Tankers rose about 5% and Nordic American Tankers climbed about 6.7%. The move matters because DHT is a pure-play crude tanker owner, with most of its fleet made up of VLCCs — very large crude carriers that move oil on long-haul routes. That puts the stock close to the freight market: when spot rates (short-term charter prices)
7 January 2026
········
Bloom Energy stock jumps as $600 million Wells Fargo credit line and $502 million Quanta microgrid deal draw fresh attention NEW YORK,

Bloom Energy stock jumps as $600 million Wells Fargo credit line and $502 million Quanta microgrid deal draw fresh attention NEW YORK,

Jan 7, 2026, 11:43 EST — Regular session Bloom Energy Corp (NYSE: BE) shares rose 8.1% to $111.38 on Wednesday, lifting off an intraday low of $100.87, as investors refocused on a new $600 million bank line and a large fuel-cell microgrid purchase linked to Quanta. The stock hit an intraday high of $111.41 and traded more than 8.3 million shares by late morning, keeping the $100 level in play for traders after the early slide. The move matters because Bloom has become a sensitive read-through on on-site power demand, a corner of the market that has drawn attention as
7 January 2026
·····
1 … 857 858 859 860 861 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop